Quantcast

Latest Roche Stories

2011-05-05 08:00:00

NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Susan Graf, of Nutley, N.J., Global Head of Strategic Evaluation and Due Diligence in Roche Partnering, was honored as a 2011 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon today in New York City. "I have had the pleasure of working with Susan on a number of projects over the past few years. We are all extremely proud of her and fully aware of the many contributions she has made to the...

2011-05-05 08:00:00

NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Two Roche employees are being recognized for their significant contributions to industry in New Jersey at the 37th Annual TWIN Awards Dinner held May 5, 2011. Honored were Maria Fuentes, Ph.D., Director, Respiratory Drug Discovery, and Maryann Szabo, R.N., Director, U.S. Affiliate Regional Monitoring Network. "These individuals are exceedingly deserving of this recognition. They have made outstanding contributions to Roche, to the pharmaceutical...

2011-04-25 05:45:00

PRINCETON, N.J., April 25, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended March 31, 2011. Financial Results Revenues were $0.2 million during the quarter ended March 31, 2011 compared to $0.3 million for the quarter ended March 31, 2010 and include amortization of...

2011-04-08 21:47:00

ATLANTIC CITY, N.J., April 8, 2011 /PRNewswire/ -- Hagens Berman LLP, a nationally recognized law firm today praised a jury's verdict that ordered pharmaceutical company Roche (ROG:VX) to pay $2 million to a woman who suffered serious gastrointestinal damage caused by the drug Accutane, while denying similar claims of actor James Marshall and another plaintiff. (Logo: http://photos.prnewswire.com/prnh/20080317/AQM144LOGO) Accutane, along with its active ingredient, isotretinoin, was...

2011-03-28 08:05:00

NUTLEY, N.J., March 28, 2011 /PRNewswire/ -- Roche announced today that Janet Hammond, MD, Ph.D., has joined the company as Vice President, Translational Medicine - Virology in Pharmaceutical Research and Early Development (pRED). In her new role, Janet will report to Jacques Banchereau, Ph.D., Discovery and Translational Area (DTA) Head for Inflammation and Virology, and Chief Scientific Officer at Nutley, and be responsible for driving strategy and implementation of early clinical...

2011-03-22 07:00:00

MADISON, Wis., March 22, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCell® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of developing drug candidates was completed early and is now transitioning into a standard supply agreement. Moving forward, iCell Cardiomyocytes, induced pluripotent stem cell...

2011-02-23 10:18:00

INDIANAPOLIS and FORT BRAGG, N.C., Feb. 23, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S. Department of Defense (DOD) to provide remote service and support for its lab analyzers at Womack Army Medical Center through the DOD's secure B2B gateway. Roche is the first in-vitro (test tube) diagnostics manufacturer to be approved by the DOD for this remote access. The B2B gateway is a highly secure portal that enables...

2011-02-16 00:00:00

SAN DIEGO, Feb. 16, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) and Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the first patient received subcutaneous (SC) MabThera (rituximab), an anticancer biologic, in a Phase 3 registration trial using Enhanze((TM) technology (rHuPH20, recombinant human hyaluronidase). This represents the second Roche cancer medicine, in addition to Herceptin® SC (trastuzumab), to enter a Phase 3 registration study as...

2011-02-07 15:30:00

PRINCETON, N.J., Feb. 7, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended December 31, 2010. Financial Results Revenues were $0.2 million during the quarter ended December 31, 2010 compared to $0.3 million for the quarter ended December 31, 2009 and include...

2011-02-01 10:29:00

MANNHEIM, Germany, Feb. 1, 2011 /PRNewswire/ -- An innovative diabetes management concept including structured self-monitoring of blood glucose (SMBG), data visualization, pattern analysis and derived therapy adjustments can significantly reduce HbA1c values, improve glycemic control and enhance patients' quality of life. These are the key findings of the 12-month data from the Structured Testing Protocol (STeP) Study, newly published in Diabetes Care.(1) Self-monitoring of blood glucose...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related